Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03348189 · ClinicalTrials.gov registry record
SpO2 Hypoxia Accuracy Validation Study
A clinical trial of Hypoxia, sponsored by Nonin Medical.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT03348189: Completed study of Hypoxia, sponsored by Nonin Medical.
NCT03348189 is a study of Hypoxia that has completed, run by Nonin Medical. The registered enrollment target is 12 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03348189, a study of Hypoxia, has completed, sponsored by Nonin Medical.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the % oxygen saturation by pulse oximetry accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.
Primary Outcome
Values from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.
Conditions Studied
Interventions
- OTHER Pulse Oximeter
Study Locations (1)
Colorado
- Clinimark - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2017-11-03 |
What the finished NCT03348189 record still lists
NCT03348189 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Pulse Oximeter is the first listed.
NCT03348189 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03348189 about?
NCT03348189 is a clinical study titled "SpO2 Hypoxia Accuracy Validation Study". The primary objective of this study is to evaluate the % oxygen saturation by pulse oximetry accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.
What is the current status of trial NCT03348189?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2017-11-01. Estimated completion is 2017-11-03.
What conditions does trial NCT03348189 study?
This clinical trial studies the following conditions: Hypoxia.
What interventions are being tested in trial NCT03348189?
The interventions under investigation include: Pulse Oximeter (OTHER).
Who is sponsoring clinical trial NCT03348189?
This trial is sponsored by Nonin Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03348189 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03348189's enrollment target sits among peer trials
12 30th of 39 higher than 3 of 39 other Hypoxia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Intravenous Iron Effects on Performance at High Altitude
RECRUITING · Phase 4
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
-
Pulse Oximeter Accuracy in Healthy Humans During Hypoxia
RECRUITING
-
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI